Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-082131
Filing Date
2024-03-29
Accepted
2024-03-29 16:47:47
Documents
5
Effectiveness Date
2024-03-29

Document Format Files

Seq Description Document Type Size
1 S-8 d807137ds8.htm S-8 60476
2 EX-5.1 d807137dex51.htm EX-5.1 6523
3 EX-23.1 d807137dex231.htm EX-23.1 1638
4 EX-FILING FEES d807137dexfilingfees.htm EX-FILING FEES 23935
5 GRAPHIC g807137g0328141219768.jpg GRAPHIC 3252
  Complete submission text file 0001193125-24-082131.txt   98297
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278394 | Film No.: 24804586
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)